A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
Cynthia Helms(Washington University in St. Louis), A. Bowcock(Imperial College London), Michael Heffernan(Washington University in St. Louis), Li Cao(Shanghai Jiao Tong University), Francesca Chamian(Rockefeller University), Pui–Yan Kwok(University of California, San Francisco), Jürg Ott(Rockefeller University), Derek Gordon(Rockefeller University), Jil Daw(Washington University in St. Louis), Alan Menter(Baylor Medical Center at Garland), Jason Robarge(Washington University in St. Louis), James G. Krueger(Rockefeller University), Ellen M. Wijsman(University of Washington Medical Center)
Cited by 303
Related Papers
Pathogenesis and therapy of psoriasis
|Nature|2007|1.8k
Immunology of Psoriasis
|Annual Review of Immunology|2014|1.6k
Frequent Mutation of <i>BAP1</i> in Metastasizing Uveal Melanomas
|Science|2010|1.5k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k